Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".
(Updates from 11:02 a.m. ET with closing information and corrects CAT ticker symbol.)
NEW YORK ( TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk On The Street" Tuesday:
Biogen Idec (BIIB - Get Report) is one of the "three horsemen" of this era, along with Celgene (CELG) and Gilead Sciences (GILD), he said. BIIB''s "great MS drug is apparently taking off. What a great company," Cramer said. BIIB fell 1.1% to $212.76.On Travelers (TRV - Get Report), he said the insurer raised rates and had fewer payouts, making it a win-win. TRV ended th eday 2.1% higher at $86.35. He said Caterpillar (CAT) has recently gotten into mining but he's not enamored of all mining companies. Is Newmont Mining (NEM - Get Report) "a good bet now? I'm not sure," he said. NEM fell 2.9% to $32.43. J. C. Penney (JCP - Get Report) has been basking under the "halo effect" recently, Cramer said, but it's wearing off. JCP fell 1% to $15.45. Cramer said Noble Energy (NBL - Get Report) believes itself undervalued and he agrees. He pointed out the company has "unbelievable natural gas reserves off the coasts of Israel and Cyprus." NBL ended the day 1.9% higher at $110.72. To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here. -- Written by Anthony Buccino in New York. Follow Anthony on Twitter @AnthonyBuccino or get updates on Facebook, AuthorABuccino
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts